Fibrinogen, cigarette smoking, and risk of cardiovascular disease: Insights from the Framingham Study

American Heart Journal

Volumn 113, Issue 4, 1987, Pages 1006-1010

  Kannel, William B ^a,b   D'Agostino, Ralph B ^a,b   Belanger, Albert J ^a,b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

ADULT; BLOOD AND HEMOPOIETIC SYSTEM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CIGARETTE SMOKING; EPIDEMIOLOGY; FOLLOW UP; FRAMINGHAM HEART STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK;

AGED; CORONARY ARTERIOSCLEROSIS; FEMALE; FIBRINOGEN; HEART DISEASES; HUMAN; MALE; MIDDLE AGE; RISK; SMOKING; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023154903     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/0002-8703(87)90063-9     Document Type: Article

References (11)

1. Haemostatic function and cardiovascular death: early results of a prospective study
2. Fibrinogen as a risk factor for stroke and myocardial infarction
3. Plasma fibrinogen—a major coronary risk factor
4. Some characteristics related to the incidence of cardiovascular disease and death: Framingham study. 18-year follow-up. Section 30
5. Some methodologic problems in the long-term study of cardiovascular diseases: observations from the Framingham study
6. Fibrinogen assay
7. Estimation of the probability of an event as a function of several independent variables
8. Latest perspective on cigarette smoking and cardiovascular disease: the Framingham study
9. Smoking: health effects and control
10. Thormbosis and acute coronary artery lesions in sudden cardiac ischemic death